Volume 190, Issue 4, April 2024

Familial hyperaldosteronism: an European Reference Network on Rare Endocrine Conditions clinical practice guideline

• Abstract
• View article
• Supplementary data

International consensus on mitotane treatment in pediatric patients with adrenal cortical tumors: indications, therapy, and management of adverse effects

• Abstract
• View article

Directed acyclic graphs in clinical research

• Abstract
• View article

The bile–gut axis and metabolic consequences of cholecystectomy

• Abstract
• View article

Impact of exenatide on weight loss and eating behavior in adults with craniopharyngioma-related obesity: the CRANIOEXE randomized placebo-controlled trial

• Abstract
• View article
• Supplementary data

Heterozygous gain of function variant in GUCY1A2 may cause autonomous ovarian hyperfunction

• Abstract
• View article
• Supplementary data

Frequency of stress dosing and adrenal crisis in paediatric and adult patients with congenital adrenal hyperplasia: a prospective study

• Abstract
• View article
• Supplementary data

A novel mutation in the NR3C1 gene associated with reversible glucocorticoid resistance

• Abstract
• View article
• Supplementary data

Functional evaluation of a novel nonsense variant of the calcium-sensing receptor gene leading to hypocalcemia

• Abstract
• View article

Real-world experience with 11C-methionine positron emission tomography in the management of acromegaly

• Abstract
• View article
• Supplementary data

Colesevelam has no acute effect on postprandial GLP-1 levels but abolishes gallbladder refilling

• Abstract
• View article

Monitoring adrenal insufficiency through salivary steroids: a pilot study

• Abstract
• View article
• Supplementary data

Early life poly- and perfluoroalkyl substance levels and adiposity in the first 2 years of life

• Abstract
• View article

Moderate salt restriction in primary aldosteronism improves bone metabolism through attenuation of urinary calcium and phosphate losses

• Abstract
• View article